Group items tagged

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 - 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)

[Price: $4650] [No of slides - 111 ] Browse market tables and figures/charts on Autologous Stem Cell & Non-stem Cell Therapy Market report includes applications of the technology and trends in terms of ACT market size and growth of autologous cellular therapies in medical treatments globally.

Major players in the global cell counting market include Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

Major players in the global cell counting market include Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

Major players in the global cell counting market include Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

The global cell counting market is mainly dominated by six players that accounted for around 65% to 70% of the global market share in 2014. However, new players in the market are intensifying competition and thereby threatening the market share of the existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market and thereby help the industry to solve the existing challenges.

[Price: $4650] [No of slides - 130] Browse 9 tables and 26 figures/charts on Transfection Market analysis & categorizes (Gene, DNA, Protein, SiRNA, Cell Transfection) the market size and global revenue has been forecasted based on four segmentation: technology, products, applications and by geography.

Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018

The nerve repair and regeneration market is categorized into two major segments, namely, peripheral nerve repair (direct nerve repair, nerve grafting, and stem cell therapy) and neuromodulation.

The global biopharmaceuticals market is set to exhibit a CAGR of 7.83% during 2019-2026 and is estimated to reach a market value of US $ XX billion by 2026. Biopharmaceuticals are large and complex molecular drugs that are mainly obtained from proteins and nucleic acids of living organisms such as microorganisms and animal cells also known as transgenic organisms. These drugs are obtained using biotechnology and have high-therapeutic value. Biopharmaceuticals are also known as biologics and biotech drugs and are usually administered by intravenous, subcutaneous, or intramuscular injections and are more efficient than the conventional small molecule drugs. Biopharmaceuticals are an alternative to the previously less effective and sometimes unsafe treatments and offer several benefits. Biopharmaceuticals benefits include highly effective and potent action, fewer side effects, can be tailored according to specific medical requirements of patients and they hold the potential to actually cure diseases at the root level. Biopharmaceuticals have reduced the number of deaths due to cancer and HIV/AIDS in the past decade and have changed the treatment of several chronic diseases, such as diabetes and cardiovascular diseases. Download free Report Sample: https://www.datamintelligence.com/download-sample/biopharmaceuticals-market View Full Report Sample: https://www.datamintelligence.com/research-report/biopharmaceuticals-market

Chronic Immune Thrombocytopenia (chronic ITP) is an autoimmune disorder in which patients produce antiplatelet autoantibodies and specialized white blood cells that destroy their blood platelets and, in some cases, damage their megakaryocytes, causing a decrease in platelet production. The global chronic immune thrombocytopenia market size was worth $ XX billion in 2019 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period (2019-2026). View Full Report Sample: https://www.datamintelligence.com/research-report/chronic-immune-thrombocytopenia-market Download free Report Sample: https://www.datamintelligence.com/download-sample/chronic-immune-thrombocytopenia-market

Glutathione is the master detoxifier and the body's main endogenous antioxidant. Toxins are linked to glutathione, which then carries them into the bile and the stool, and out of the body. Glutathione protects our cells' delicate chemical machinery and helps energy metabolism run efficiently.